Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Quipt Home Medical (QIPT) EBITDA (2023 - 2025)

Quipt Home Medical (QIPT) has disclosed EBITDA for 3 consecutive years, with $11.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA rose 20.01% year-over-year to $11.9 million, compared with a TTM value of $37.6 million through Dec 2025, down 3.14%, and an annual FY2025 reading of $35.6 million, down 10.1% over the prior year.
  • EBITDA was $11.9 million for Q4 2025 at Quipt Home Medical, up from $8.9 million in the prior quarter.
  • Across five years, EBITDA topped out at $11.9 million in Q4 2025 and bottomed at $7.9 million in Q2 2025.
  • Average EBITDA over 3 years is $9.7 million, with a median of $9.7 million recorded in 2024.
  • Peak annual rise in EBITDA hit 20.01% in 2025, while the deepest fall reached 18.0% in 2025.
  • Year by year, EBITDA stood at $10.7 million in 2023, then decreased by 7.43% to $9.9 million in 2024, then rose by 20.01% to $11.9 million in 2025.
  • Business Quant data shows EBITDA for QIPT at $11.9 million in Q4 2025, $8.9 million in Q3 2025, and $7.9 million in Q2 2025.